Dcvc Opportunity Fund Ii Gp, LLC Recursion Pharmaceuticals, Inc. Transaction History
Dcvc Opportunity Fund Ii Gp, LLC
- $81.5 Million
- Q1 2025
A detailed history of Dcvc Opportunity Fund Ii Gp, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Dcvc Opportunity Fund Ii Gp, LLC holds 3,951,141 shares of RXRX stock, worth $18.1 Million. This represents 25.65% of its overall portfolio holdings.
Number of Shares
3,951,141
Previous 3,951,141
-0.0%
Holding current value
$18.1 Million
Previous $26.7 Million
21.75%
% of portfolio
25.65%
Previous 23.63%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$159 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$148 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$111 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$79.1 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$67 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $825M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...